GeneDx Holdings Corp. (WGSWW) financials · rev $427.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
GeneDx Holdings Corp. (WGSWW) rev $427.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $427.5M | $305.4M |
| Cost of Revenue | $129.4M | $111.1M |
| Gross Profit | $298.2M | $194.4M |
| Operating Income | -$13.1M | -$23.2M |
| Net Income | -$21.0M | -$52.3M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $523.7M | $419.4M |
| Current Assets | $268.3M | $198.0M |
| Cash & Equivalents | $105.0M | $85.2M |
| Inventory | $14.0M | $10.7M |
| PP&E | $45.7M | $32.9M |
| Total Liabilities | $215.5M | $174.1M |
| Current Liabilities | $108.9M | $54.8M |
| Short-term Debt | $4.54M | $1.21M |
| Long-term Debt | $48.2M | $51.9M |
| Total Debt | $52.7M† | $53.1M† |
| Shareholders' Equity | $308.2M | $245.2M |
| Retained Earnings | -$1.37B | -$1.35B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $33.3M | -$28.5M |
| CapEx | $19.0M | $5.49M |
| Investing Cash Flow | -$61.5M | -$30.1M |
| Financing Cash Flow | $48.0M | $44.2M |
| Net Change in Cash | $19.8M | -$14.5M |
| Free Cash Flow | $14.3M | -$34.0M |
FAQ
What is WGSWW P/E and revenue?
GeneDx Holdings Corp. (WGSWW) rev $427.5M.
What is WGSWW revenue?
GeneDx Holdings Corp. last cached revenue is $427.5M (FY2025).
Is WGSWW profitable?
GeneDx Holdings Corp. last cached net income is -$21.0M (FY2025).
What are WGSWW total assets?
GeneDx Holdings Corp. last cached total assets are $523.7M (FY2025).
What is WGSWW free cash flow?
GeneDx Holdings Corp. last cached free cash flow is $14.3M (FY2025).
Not investment advice. Cached statements, not a live tape.